Items where authors include "Platt, FM"

Article

Pettitt, GA, Hurst, CD, Khan, Z et al. (7 more authors) (2023) Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro. Journal of Pathology, 259 (2). pp. 220-232. ISSN 0022-3417

Hurst, CD, Cheng, G, Platt, FM et al. (7 more authors) (2022) Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling. The Journal of Pathology: Clinical Research, 8 (3). pp. 279-293. ISSN 2056-4538

Hurst, CD, Cheng, G, Platt, FM et al. (16 more authors) (2021) Stage-stratified molecular profiling of non-muscle-invasive bladder cancer provides improved biological, clinical and therapeutic insights. Cell Reports Medicine, 2 (12). 100472. ISSN 2666-3791

Hurst, CD orcid.org/0000-0001-7719-1325, Alder, O orcid.org/0000-0002-7975-9727, Platt, FM et al. (15 more authors) (2017) Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. Cancer Cell, 32 (5). pp. 701-715. ISSN 1535-6108

Taylor, CF, Platt, FM, Hurst, CD orcid.org/0000-0001-7719-1325 et al. (2 more authors) (2014) Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes. Human Molecular Genetics, 23 (8). pp. 1964-1974. ISSN 0964-6906

De Faveri, LE, Hurst, CD orcid.org/0000-0001-7719-1325, Platt, FM et al. (5 more authors) (2013) Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer. British Journal of Cancer, 108 (6). pp. 1368-1377. ISSN 0007-0920